| 1 |
30926892 | Efficacy and Safety of Pioglitazone Monotherapy in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. | 2019 Mar 29 |
1 |
| 2 |
31376066 | Post-authorisation Safety Study of Pioglitazone Use and Safety Endpoints of Interest in Denmark After Direct Healthcare Professional Communication. | 2019 Sep |
1 |
| 3 |
28589542 | Is insulin the preferred treatment for HbA1c >9%? | 2017 Sep |
1 |
| 4 |
28847910 | Pioglitazone Improves Left Ventricular Diastolic Function in Subjects With Diabetes. | 2017 Nov |
1 |
| 5 |
29362626 | Comparative Study on Adding Pioglitazone or Sitagliptin to Patients with Type 2 Diabetes Mellitus Insufficiently Controlled With Metformin. | 2017 Dec 15 |
1 |
| 6 |
27762511 | A Study of Effects of Pioglitazone and Rosiglitazone on Various Parameters in Patients of Type-2 Diabetes Mellitus with Special Reference to Lipid Profile. | 2016 Sep |
1 |
| 7 |
23807528 | Efficacy and safety of adding pioglitazone or sitagliptin to patients with type 2 diabetes insufficiently controlled with metformin and a sulfonylurea. | 2013 Nov-Dec |
1 |
| 8 |
22067722 | A comparison of the effect of glitazones on serum sialic acid in patients with type 2 diabetes. | 2012 Jul |
2 |
| 9 |
21410628 | Efficacy and safety of initial combination therapy with linagliptin and pioglitazone in patients with inadequately controlled type 2 diabetes: a randomized, double-blind, placebo-controlled study. | 2011 Jul |
2 |
| 10 |
21492364 | A randomized-controlled trial to investigate the effects of rivoglitazone, a novel PPAR gamma agonist on glucose-lipid control in type 2 diabetes. | 2011 Sep |
1 |
| 11 |
21682833 | Efficacy and safety of alogliptin added to pioglitazone in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial with an open-label long-term extension study. | 2011 Nov |
3 |
| 12 |
20629618 | Fixed-dose combination therapy for type 2 diabetes: sitagliptin plus pioglitazone. | 2010 Aug |
2 |
| 13 |
19614948 | Baseline differences in A1C explain apparent differences in efficacy of sitagliptin, rosiglitazone and pioglitazone. | 2009 Nov |
1 |
| 14 |
18480556 | Acarbose treatment increases serum total adiponectin levels in patients with type 2 diabetes. | 2008 Jul |
1 |
| 15 |
19337535 | Combination therapy with DPP-4 inhibitors and pioglitazone in type 2 diabetes: theoretical consideration and therapeutic potential. | 2008 |
1 |
| 16 |
24692813 | Effects of replacing metformin with pioglitazone on glycemic control in japanese patients with poorly controlled type 2 diabetes mellitus: A 12-week, open-label, prospective study. | 2008 Aug |
1 |
| 17 |
17712875 | Effects of early use of pioglitazone in combination with metformin in patients with newly diagnosed type 2 diabetes. | 2007 Aug |
1 |
| 18 |
16492206 | Comparison of glycaemic control over 1 year with pioglitazone or gliclazide in patients with Type 2 diabetes. | 2006 Mar |
1 |
| 19 |
15662596 | Effect of pioglitazone on lipids in well controlled patients with diabetes mellitus type 2 -- results of a pilot study. | 2005 Jan |
1 |
| 20 |
16207627 | Influence of glucose control and improvement of insulin resistance on microvascular blood flow and endothelial function in patients with diabetes mellitus type 2. | 2005 Oct-Nov |
1 |
| 21 |
10983737 | Pioglitazone. | 2000 Aug |
2 |
| 22 |
11192132 | Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellitus: a randomized, placebo-controlled study. The Pioglitazone 027 Study Group. | 2000 Dec |
1 |